Exactly.
FDA has approved the name.
Advised what the label should look like.
Revenue streams in established overseas markets.
Find another FDA de risked play like this with revenue in the hundreds of millions.
Sofdra has a clear path forward.
Share price may be flat, but it will do the same as it did last time.
The run from 6c was glorious.
Just like this next run will be. Thankful we have another shot.
Exactly. FDA has approved the name.Advised what the label should...
-
- There are more pages in this discussion • 4,969 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
42.0¢ |
Change
-0.005(1.18%) |
Mkt cap ! $761.8M | |||
| Open | High | Low | Value | Volume |
| 43.0¢ | 44.5¢ | 41.5¢ | $2.435M | 5.697M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 819538 | 41.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 42.0¢ | 29052 | 2 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| BOT (ASX) Chart |